News

Each year on August 8, Severe ME/CFS Day, we pause to recognize the immense challenges faced by those living with the most debilitating form of ME/CFS. It’s a day to acknowledge the suffering, honor resilience, and remember the lives that

The 17th Invest in ME Research International ME Conference (IIMEC17) took place on May 30, 2025, in Cambridge, United Kingdom, marking the final event of International ME Conference Week 2025—a series of collaborative events featuring workshops, strategic meetings, and scientific

Today, we are pleased to share a new publication, Steroid Dynamics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Case-Control Study using Ultra Performance Supercritical Fluid Chromatography Tandem Mass Spectrometry. The Heart of the Matter OMF’s research centers in Uppsala and Melbourne

The Director of OMF’s Ronald G. Tompkins Harvard ME/CFS Collaboration, Dr. David Systrom, recently attended the International ME/CFS Conference 2025 held in Berlin, Germany. As part of the conference, he gave two presentations—one on circulatory dysfunction, and another on a

We’re excited to share a new publication from OMF’s Collaborative Center at Montreal titled: “SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.” The Heart of the Matter The team at OMF’s Collaborative Center at Montreal published a paper

From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations In the past, I’ve shared some information about the peer-review publication process—the last stage of the research process—and the concept of a preprint. We recognize that the

From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Today, I’m happy to share another update on a study that I introduced back in November 2024 in an interview with Dr. Systrom. The study is still

Today, we’re sharing an update on important developments in ME/CFS research — work that is steadily improving our understanding of the biology behind this complex and often life-altering condition. Whether a person’s ME/CFS began decades ago or more recently, the

From the Desk of Dr. Danielle Meadows, Vice President of Research Programs & Operations In the fall of 2024, I introduced to you all an overview of the research process, where studies typically move through four main stages: Study Design,

In May, I had the privilege of attending the 2025 Invest in ME Research International Conference in Cambridge, UK, along with OMF’s research Directors. This annual event brings together scientists, clinicians, and advocates committed to advancing ME/CFS and Long COVID